References
- Freedberg KA, Losina E, Weinstein MC et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N. Engl. J. Med.344(11), 824–831 (2001).
- Lai DJ, Tarwater PM, Hardy RJ. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000. Public Health120(6), 486–492 (2006).
- Greene William H. Econometric Analysis Third Edition. Prentice-Hall, NJ, USA (1997).
- Murphy KM, Topel RH. The Economic Value of Medical Research. In: Measuring the Gains from Medical Research: An Economic Approach, Murphy KM, Topel RH (Eds), University of Chicago Press, IL, USA (2003).
Websites
- FDA, Office of Special Health Issues, Drugs Used in the Treatment of HIV Infection www.fda.gov/oashi/aids/virals.html
- Duggan MG, Evans WN. Estimating the Impact of Medical Innovation: The Case of HIV Antiretroviral Treatments, NBER Working Paper No. 11109, February 2005 www.nber.org/papers/w11109.
- CDC, AIDS Public Information Data Set www.cdc.gov/hiv/software/apids.htm
- Centers for Disease Control, AIDS Public Information Data Summary wonder.cdc.gov/wonder/help/aids.html
- Arias E. United States life tables, 2002. National vital statistics reports; vol 53 no 6. Hyattsville, Maryland: National Center for Health Statistics. 2004 www.cdc.gov/nchs/data/nvsr/nvsr53/nvsr53_06.pdf
- Centers for Disease Control & Prevention, National Center for HIV, STD, and TB Prevention, Divisions of HIV/AIDS Prevention, Surveillance Branch www.cdc.gov/HIV/graphics/mortalit.htm
- HCUPnet, Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD www.ahrq.gov/HCUPnet/
- HIVnet. HIV Resource Utilization Data Coordinating Center (DCC) project. February 2003. Agency for Healthcare Research and Quality, Rockville, MD www.ahrq.gov/data/HIVnet.htm
- Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, Rockville, MD www.meps.ahrq.gov
- http://hcup.ahrq.gov/HCUPnet.asp